Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Valve-In-Valve Versus Explantation for Failed TAVR (REVIVE-TAVR)

NCT06400342 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT06400342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06400342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Valve-In-Valve Versus Explantation for Failed TAVR (REVIVE-TAVR)
Lead sponsor
Medstar Health Research Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
May 1, 2036
Enrollment
264 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prosthesis failure, prosthetic valve malfunction, symptomatic patients who have had transcatheter heart valve (thv) failure